Abilify SNDA For Pediatric Patients With Schizophrenia Accepted …
10 Jun
Posted by as Uncategorized
Otsuka Pharmaceutical Co, Ltd., and Bristol-Myers Squibb Company (NYSE: BMY) have announced that the US Food and Drug Administration (FDA) has accepted for priority (six month review target) review …
article continues at unknown brought to you by diabetes.medtrials.info and medtrials.info
Categories
Archives
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
- August 2007
- July 2007
- June 2007
- May 2007
- April 2007
- March 2007
- February 2007
- January 2007
- December 2006
- November 2006
- July 2006
- November 2005
- September 2005
Meta
diabetes.MEDtrials.info is proudly powered by WordPress - BloggingPro theme by: Design Disease
Powered by FireStats
RSS feed for comments on this post · TrackBack URI
Leave a reply